Literature DB >> 20875795

Immunological basis of M13 phage vaccine: Regulation under MyD88 and TLR9 signaling.

Shuhei Hashiguchi1, Yuya Yamaguchi, Osamu Takeuchi, Shizuo Akira, Kazuhisa Sugimura.   

Abstract

Peptide-displaying bacteriophages induce mimotope-specific antibody responses, suggesting a novel application of phage-display library as bacteriophage vaccine. We examined the antibody response against M13 phage in mice induced by an i.p. administration of M13 phage in phosphate-buffered saline. We showed here that firstly, mice showed strong IgG antibody responses, particularly, in IgG2b, IgG2c, and IgG3 subclasses even in primary responses. Secondly, IgG production in primary response is totally dependent on MyD88 signaling. These responses were almost comparable, but slightly weaker, in TLR2-, TLR4- and TLR7-deficient mice relative to wild-type mice, suggesting that this enhancing effect is not due to plausible LPS contamination. Thirdly, although primary IgG1 response was not detected in wild-type mice, remarkable IgG1 response was induced in TLR9-deficient mice, suggesting that TLR9 pathway functions as regulatory, but not a simple augmenting signaling cascade, and furthermore, the enhanced IgG1 response was not due to adjuvant effect of single-stranded DNA derived from M13 phage. Thus, innate immunity including TLR regulation is crucial for M13 phage vaccine design.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20875795     DOI: 10.1016/j.bbrc.2010.09.094

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Developing strategies to enhance and focus humoral immune responses using filamentous phage as a model antigen.

Authors:  Kevin A Henry; Armstrong Murira; Nienke E van Houten; Jamie K Scott
Journal:  Bioeng Bugs       Date:  2011-09-01

Review 2.  Phage display--a powerful technique for immunotherapy: 2. Vaccine delivery.

Authors:  Justyna Bazan; Ireneusz Całkosiński; Andrzej Gamian
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

Review 3.  Application of phage peptide display technology for the study of food allergen epitopes.

Authors:  Xueni Chen; Stephen C Dreskin
Journal:  Mol Nutr Food Res       Date:  2017-02-08       Impact factor: 5.914

Review 4.  Biological foundations of successful bacteriophage therapy.

Authors:  Carola Venturini; Aleksandra Petrovic Fabijan; Alicia Fajardo Lubian; Stefanie Barbirz; Jonathan Iredell
Journal:  EMBO Mol Med       Date:  2022-05-27       Impact factor: 14.260

Review 5.  Phages in vaccine design and immunity; mechanisms and mysteries.

Authors:  Christiaan R de Vries; Qingquan Chen; Sally Demirdjian; Gernot Kaber; Arya Khosravi; Dan Liu; Jonas D Van Belleghem; Paul L Bollyky
Journal:  Curr Opin Biotechnol       Date:  2020-12-11       Impact factor: 9.740

Review 6.  Novel therapeutic interventions towards improved management of septic arthritis.

Authors:  Jian Wang; Liucai Wang
Journal:  BMC Musculoskelet Disord       Date:  2021-06-09       Impact factor: 2.362

7.  MyD88 signaling in B cells regulates the production of Th1-dependent antibodies to AAV.

Authors:  Muriel Sudres; Séverine Ciré; Virginie Vasseur; Léa Brault; Sylvie Da Rocha; Florence Boisgérault; Christine Le Bec; David Alexandre Gross; Véronique Blouin; Bernard Ryffel; Anne Galy
Journal:  Mol Ther       Date:  2012-05-29       Impact factor: 11.454

8.  Cowpea mosaic virus stimulates antitumor immunity through recognition by multiple MYD88-dependent toll-like receptors.

Authors:  Chenkai Mao; Veronique Beiss; Jennifer Fields; Nicole F Steinmetz; Steven Fiering
Journal:  Biomaterials       Date:  2021-05-25       Impact factor: 12.479

Review 9.  Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy.

Authors:  Christine E Boone; Lu Wang; Aayushma Gautam; Isabel G Newton; Nicole F Steinmetz
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-07-22

Review 10.  Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold.

Authors:  Kevin A Henry; Mehdi Arbabi-Ghahroudi; Jamie K Scott
Journal:  Front Microbiol       Date:  2015-08-04       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.